ANA, antinuclear antibodies

Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study
H Marzo-Ortega, D McGonagle, S Jarrett, G Haugeberg, E Hensor, P O’Connor, A L Tan, P G Conaghan, A Greenstein, P Emery

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1568-1575; DOI: 10.1136/ard.2004.022582
Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies
T Jonsdottir, J Forslid, A van Vollenhoven, A Harju, S Brannemark, L Klareskog, R F van Vollenhoven

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1075-1078; DOI: 10.1136/ard.2003.018093
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
I E A Hoffman, I Peene, L Meheus, T W J Huizinga, L Cebecauer, D Isenberg, K De Bosschere, F Hulstaert, E M Veys, F De Keyser

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1155-1158; DOI: 10.1136/ard.2003.013417
Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases
M G Tektonidou, M Anapliotou, P Vlachoyiannopoulos, H M Moutsopoulos

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1159-1161; DOI: 10.1136/ard.2004.022624
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf, C Iking-Konert, K Kurz, G Jung, O Sander, M Schneider

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 630-633; DOI: 10.1136/ard.2004.025858
Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up
E Kruithof, F Van den Bosch, D Baeten, A Herssens, F De Keyser, H Mielants, E M Veys

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 207-212; DOI: 10.1136/ard.61.3.207
Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis
M Fathi, M Dastmalchi, E Rasmussen, I E Lundberg, G Tornling

Annals of the Rheumatic Diseases Mar 2004, 63 (3) 297-301; DOI: 10.1136/ard.2003.006122
Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis
T J A Lehman, B S Edelheit, K B Onel

Annals of the Rheumatic Diseases Mar 2004, 63 (3) 321-323; DOI: 10.1136/ard.2003.008342

Log in using your username and password

Main menu

Log in using your username and password

You are here

ANA, antinuclear antibodies